Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Obesity Studies

Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging

An Adipokine-Mediated Process?

  1. Ilan Gabriely12,
  2. Xiao Hui Ma12,
  3. Xiao Man Yang12,
  4. Gil Atzmon12,
  5. Michael W. Rajala3,
  6. Anders H. Berg3,
  7. Phillip Scherer3,
  8. Luciano Rossetti1 and
  9. Nir Barzilai12
  1. 1Diabetes Research and Training Center and Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
  2. 2Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York
  3. 3Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York
    Diabetes 2002 Oct; 51(10): 2951-2958. https://doi.org/10.2337/diabetes.51.10.2951
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • FIG. 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 1.

      Peripheral insulin sensitivity in aging rats. Shown are results for young (2-month-old) and old (20-month-old) F1 hybrids of F344 and Brown Norway rats. The old rats underwent VF removal (VF−), SC fat removal (SC−), or sham operation (SO), or they were calorically restricted (see research design and methods). Glucose uptake (Rd) during hyperinsulinemic (6 mU · kg−1 · min−1) pancreatic clamps is shown. *P < 0.001 vs. SC− and SO rats.

    • FIG. 2.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 2.

      Hepatic insulin sensitivity in aging rats. The ability of insulin to suppress EGP was studied using glucose tracer methodology (see research design and methods). * P < 0.001 vs. SC− and SO rats. Ra, rate of EGP.

    • FIG. 3.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 3.

      Development of diabetes and the regrowth of VF in ZDF rats. At 2 months of age, rats were assigned to either have their epididymal and perirenal fat removed (ZDVF−, n = 12) or undergo a sham operation (ZDVF+, n = 12). Six rats from each group were studied using a pancreatic clamp, and the rest were monitored for 4 months until they developed diabetes. The six ZDVF− rats studied at 4 months had 38% of the fat observed in ZDVF+ rats. When diabetes (defined as glucose >12 mmol/l) appeared, ZDVF− VF accounted for 82% of that observed in ZDVF+ rats. *Percent VF in ZDVF− versus ZDVF+ rats.

    • FIG. 4.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 4.

      Gene expression of TNF-α and leptin. Measurements were performed in epididymal (E), perinephric (R), mesenteric (M), and SC fat after extraction of VF (VF−) or SC fat (SC−). RT and real-time PCR analysis for TNF-α, leptin, and β-actin are described in research design and methods. A: Example of agarose gel analysis of RT-PCR products from different fat depots in SC− and VF− rats. B: Analysis of all real-time PCR data obtained in all rats, corrected for intensity of β-actin and presented in arbitrary units. P < 0.001 vs. mesenteric fat.

    • FIG. 5.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 5.

      Gene expression of resistin (A) and ACRP30 (B). A: Northern blot analysis of brown (B), epididymal (E), perinephric (R), mesenteric (M), and SC fat obtained from SC− rats. B: Real-time PCR data obtained from all rats corrected for the intensity of β-actin and presented in arbitrary units. *P < 0.01 vs. M and SC.

    Tables

    • Figures
    • TABLE 1

      Body composition and fat distribution of aging rats


      young
      SO
      SC−
      VF−
      CR
      n66868
      VF/SC removed (g)0014.9 ± 1.715.7 ± 1.30
      Body weight (g)291 ± 13478 ± 19*451 ± 14*452 ± 20*303 ± 9
      Lean body mass (g)264 ± 14373 ± 14*364 ± 14*372 ± 20*266 ± 8
      Non-VF fat mass (g)21 ± 582 ± 10*65 ± 11*75 ± 10*32 ± 6
      Total VF after study (g)5.8 ± 0.923.4 ± 4.3*21.3 ± 1.6*4.6 ± 0.7†6.1 ± 1.0
      Epididymal (g)2.9 ± 0.39.2 ± 1.6*8.2 ± 0.7*0.1 ± 0.1†2.6 ± 0.5
      Perinephric (g)1.4 ± 0.38.3 ± 0.7*8.1 ± 0.6*0.4 ± 0.4†1.9 ± 0.5
      Mesenteric (g)1.5 ± 0.35.9 ± 0.4*4.8 ± 0.6*4.1 ± 0.4*1.4 ± 0.4
      • young (2-month-old), and old (20-month-old) F1 hybrids of F344 and Brown Norway rats were used in these experiments. The old rats underwent VF removal (VF−), SC fat removal (SC−), sham operation (SO), or CR (see research design and methods). The table depicts the amounts of VF or SC removed at the surgery, body weight, lean body mass, non-VF fat mass, total VF, and epididymal, perinephric, and mesenteric fat, which were determined at killing after the experiments.

      • *

        * P < 0.001 vs. young and CR;

      • †

        † P < 0.01 vs. young, CR, and SC−. All data are presented as means ± SE.

    • TABLE 2

      Metabolic characteristics of aging rats


      young
      SO
      SC−
      VF−
      CR
      n66868
      Glucose (mmol/l)
       Basal7.2 ± 0.27.6 ± 0.57.4 ± 0.77.7 ± 0.37.2 ± 0.7
       Clamp7.3 ± 0.37.5 ± 0.37.5 ± 0.47.6 ± 0.37.3 ± 0.7
      Insulin (μU/ml)
       Basal14 ± 229.5 ± 3.5*25 ± 2*18 ± 215 ± 2
       Clamp98 ± 1396 ± 10102 ± 11102 ± 2292 ± 18
      FFA (mmol/l)
       Basal0.99 ± 0.151.1 ± 0.240.81 ± 0.141.06 ± 0.141.11 ± 0.11
       Clamp0.21 ± 0.080.35 ± 0.10.23 ± 0.10.27 ± 0.040.32 ± 0.03
      Ra (mg · kg−1 · min−1)
       Basal12.1 ± 0.49.1 ± 0.3*8.7 ± 0.2*10.7 ± 0.311.0 ± 0.8
      GIR (mg · kg−1 · min−1)
       Clamp21.3 ± 3.08.4 ± 4.2*10.4 ± 3.2*18.0 ± 2.021.8 ± 4.6
      Gly (mg · kg−1 · min−1)
       Basal7.1 ± 0.66.0 ± 0.26.4 ± 0.56.2 ± 0.37.4 ± 0.7
       Clamp14.4 ± 1.56.9 ± 0.4*8.6 ± 1.4*14.7 ± 2.113.7 ± 2.0
      GS (mg · kg−1 · min−1)
       Basal5.0 ± 0.73.1 ± 0.1*2.3 ± 0.5*4.4 ± 0.33.6 ± 0.3
       Clamp12.6 ± 1.45.1 ± 0.7*6.5 ± 0.6*9.3 ± 0.910.4 ± 2.4
      • Plasma glucose, insulin, FFA concentrations, basal rate of EGP (Ra), glucose infusion rate (GIR), glycolysis (Gly), and glycogen synthesis (GS) during the basal period and during the pancreatic (euglycemic) clamp are shown. These parameters were measured at basal conditions and during the insulin clamps (see group description in research design and methods).

      • *

        * P < 0.001 vs. young, VF−, and CR. All data are presented as means ± SE.

    • TABLE 3

      Body composition and fat distribution of ZDF rats

      ZDVF+ZDVF−
      n68
      VF removed (g)010.5 ± 0.3*
      Body weight (g)488 ± 17468 ± 16
      Lean body mass (g)327 ± 19313 ± 18
      Non-VF fat mass (g)121 ± 15139 ± 11
      Total VF after study(g)40.0 ± 3.815.8 ± 1.1*
      Epididymal (g)15.0 ± 2.02.0 ± 0.4*
      Perinephric (g)15.8 ± 1.75.1 ± 0.3*
      Mesenteric (g)9.2 ± 0.88.8 ± 1.2
      • At 8 weeks prior to the study, epididymal and perinephric pads were removed in ZDF (fa/fa) rats (ZDVF−), whereas sham operation was performed in control rats (ZDVF+). The table depicts the amounts of VF removed at surgery, body weight, lean body mass, non-VF fat mass, and total VF, epididymal, perinephric, and mesenteric fat that were detected after the study.

      • *

        * P < 0.001 vs. ZDF+. All data are presented as means ± SE.

    • TABLE 4

      Metabolic characteristics of ZDF rats

      BASAL
      CLAMP
      ZDVF+ZDVF−ZDVF+ZDVF−
      n6666
      Glucose (mmol/l)8.9 ± 0.48.5 ± 0.510.1 ± 0.7*8.4 ± 0.3
      Insulin (pmol/l)76 ± 9*44 ± 2112 ± 10101 ± 5
      FFA (mmol/l)1.99 ± 0.221.67 ± 0.132.53 ± 0.11*1.51 ± 0.16
      GIR (mg · kg−1 · min−1)0002.1 ± 0.6
      EGP (mg · kg−1 · min−1)13.8 ± 0.813.1 ± 1.613.3 ± 0.5*10.7 ± 0.6†
      Rd (mg · kg−1 · min−1)13.8 ± 0.813.1 ± 1.613.7 ± 0.814.2 ± 0.8
      • Plasma glucose, insulin, FFA levels, glucose infusion rate (GIR), EGP, and glucose uptake (Rd) at basal conditions and during the pancreatic clamps in ZDVF+ (no VF removed) and ZDVF− (VF removed) rats.

      • *

        * P < 0.001 vs. ZDVF−,

      • †

        † P < 0.001 vs. basal. All data are presented as means ± SE.

    PreviousNext
    Back to top

    In this Issue

    October 2002, 51(10)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging
    (Your Name) has forwarded a page to you from Diabetes
    (Your Name) thought you would like to see this page from the Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging
    Ilan Gabriely, Xiao Hui Ma, Xiao Man Yang, Gil Atzmon, Michael W. Rajala, Anders H. Berg, Phillip Scherer, Luciano Rossetti, Nir Barzilai
    Diabetes Oct 2002, 51 (10) 2951-2958; DOI: 10.2337/diabetes.51.10.2951

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging
    Ilan Gabriely, Xiao Hui Ma, Xiao Man Yang, Gil Atzmon, Michael W. Rajala, Anders H. Berg, Phillip Scherer, Luciano Rossetti, Nir Barzilai
    Diabetes Oct 2002, 51 (10) 2951-2958; DOI: 10.2337/diabetes.51.10.2951
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • RESEARCH DESIGN AND METHODS
      • RESULTS
      • DISCUSSION
      • Acknowledgments
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet
    • Placental Insulin/IGF-1 Signaling, PGC-1α, and Inflammatory Pathways Are Associated With Metabolic Outcomes at 4–6 Years of Age: The ECHO Healthy Start Cohort
    • Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver
    Show more Obesity Studies

    Similar Articles

    Navigate

    • Current Issue
    • Online Ahead of Print
    • Scientific Sessions Abstracts
    • Collections
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.